Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor V Levenson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|September 1, 2004
DNA methylation biomarkers of cancer: moving toward clinical applicationVictor V Levenson
Pharmacogenomics|June 24, 2004
Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USAVictor V Levenson
Biochimica Et Biophysica Acta|March 21, 2007
Biomarkers for early detection of breast cancer: what, when, and where?Victor V Levenson
Expert Review of Molecular Diagnostics|May 15, 2010
DNA methylation as a universal biomarkerVictor V Levenson
Pharmaceuticals (Basel, Switzerland)|November 30, 2013
DNA methylation as clinically useful biomarkers-light at the end of the tunnelVictor V Levenson, Anatoliy A Melnikov
Expert Review of Molecular Diagnostics|October 26, 2011
The MethDet: a technology for biomarker developmentVictor V Levenson, Anatoliy A Melnikov
Expert Review of Molecular Diagnostics|October 25, 2013
Molecular biomarkers in 2013Victor V Levenson, Anatoliy A Melnikov
Cancer Letters|June 29, 2004
Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistanceIrina A Davidovich, Anait S Levenson, Victor V Levenson Chernokhvostov
Cancer Letters|July 29, 2014
Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cellsLei Duan, Brian Danzer, Victor V Levenson, et al.
International Journal of Cancer|May 18, 2010
Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patientsThomas E Liggett, Anatoliy A Melnikov, Jeffrey R Marks, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|September 1, 2004
DNA methylation biomarkers of cancer: moving toward clinical applicationVictor V Levenson
Pharmacogenomics|June 24, 2004
Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USAVictor V Levenson
Biochimica Et Biophysica Acta|March 21, 2007
Biomarkers for early detection of breast cancer: what, when, and where?Victor V Levenson
Expert Review of Molecular Diagnostics|May 15, 2010
DNA methylation as a universal biomarkerVictor V Levenson
Pharmaceuticals (Basel, Switzerland)|November 30, 2013
DNA methylation as clinically useful biomarkers-light at the end of the tunnelVictor V Levenson, Anatoliy A Melnikov
Expert Review of Molecular Diagnostics|October 26, 2011
The MethDet: a technology for biomarker developmentVictor V Levenson, Anatoliy A Melnikov
Expert Review of Molecular Diagnostics|October 25, 2013
Molecular biomarkers in 2013Victor V Levenson, Anatoliy A Melnikov
Cancer Letters|June 29, 2004
Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistanceIrina A Davidovich, Anait S Levenson, Victor V Levenson Chernokhvostov
Cancer Letters|July 29, 2014
Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cellsLei Duan, Brian Danzer, Victor V Levenson, et al.
International Journal of Cancer|May 18, 2010
Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patientsThomas E Liggett, Anatoliy A Melnikov, Jeffrey R Marks, et al.
Pageof 2